News
-
Small molecule startup takes bow with £5m investment
A thrusting young life science startup in Cambridge has emerged from stealth in wealth ready to take on the world with a game-changing proposition... Read More
-
New vision for Cambridge Biomedical Campus
Cambridge Biomedical Campus is launching a new vision for the hub and wants local people to put forward their views and help shape its future. The... Read More
-
Clear blue skies as Speechmatics cracks Microsoft Azure
Speechmatics, a Cambridge-based UK leader in any-context speech recognition technology has launched on the Microsoft Azure Marketplace. The company’s... Read More
-
VividQ rearranges its C-Suite to trigger new concepts
Cambridge University spin-out VividQ has juggled its top team to initiate a new wave of display technology innovation. The fresh commercial thrust... Read More
-
San Diego company agrees to acquire Dotmatics
San Diego software provider Insightful Science has agreed to acquire Dotmatics which, from a Bishop’s Stortford base, leverages a cloud-based... Read More
-
Luxury car group invests £30m in new ‘supersite’
H.R. Owen, a luxury automotive dealer group, has begun construction on a new £30 million multi-brand site in Hatfield, Hertfordshire. ... Read More
-
PhoreMost hits its straps after $46m Series B
Cambridge biopharma business PhoreMost has raised $46 million in an oversubscribed Series B round to accelerate key treatments into the clinic.... Read More
-
Budget 2021 – Reflections
I’m getting rather good at this Budget prediction lark, even if I do say so myself – of course, it does help a great deal when significant portions... Read More
-
The support continues
In what has to be one of the most eagerly anticipated Budgets in decades, Rishi Sunak continued with his promise to “do whatever it takes” to tackle... Read More
-
Paragraf technology plugs into EV sector
Paragraf, the Cambridge-anchored leader in graphene-based transformative electronic devices, has launched a new graphene Hall Effect sensor ideally... Read More
-
Lucida Medical raises seed funding to develop AI for cancer screening
Cambridge start-up Lucida Medical has raised significant seed capital from a group of investors led by XTX Ventures and Prostate Cancer Research.... Read More
-
Cambridge Design Partnership hiring fast from new North Carolina base
Technology and product design company Cambridge Design Partnership has opened its new, state-of-the-art R & D centre in Raleigh, North Carolina.... Read More
-
Investment star turn is new Babraham chair
Babraham Bioscience Technologies Ltd, which oversees the development and 24/7 management of the Babraham Research Campus has confirmed Jo Parfrey as... Read More
-
Stansted cargo boom boosted by carriers’ $multibillion investments
Record investment in capability by the world’s largest air freight carriers is paying handsome dividends for the cargo operation at London Stansted.... Read More
-
Axol and CENSO unveil merger and $5.3m investment
Cell technology specialists Axol Bioscience and CENSO Biotechnologies have agreed to merge and announced an associated investment round of more than... Read More
-
Australian animal healthtech company creates global HQ in Cambridge
An Australian animal health MedTech company behind pioneering wireless animal monitoring technology has expanded its UK operation and established a... Read More
-
Bango on top of the world after terrific 2020
Bango plc’s share price shot northwards as soon as the UK markets opened on Tuesday after a thumping set of full year results to December 31.... Read More
-
Northwest Biotherapeutics creating 300 Cambridge UK jobs
Northwest Biotherapeutics, a Maryland-based company developing personalised cancer vaccines, has finished initial buildout of a plant in Sawston,... Read More
-
AstraZeneca nets $205m Covid antibody deal with US government
Cambridge Big Biotech AstraZeneca has modified an existing agreement with the US government to supply up to 500,000 additional doses of AZD7442 – a... Read More
-
Alchemab wins £1.6m grant to fight Huntington’s disease
Cambridge biotech startup Alchemab has won a UK Biomedical Catalyst grant believed to be worth £1.6 million to support the development of a novel... Read More